CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
Liu CC, Yang WB, Chien CH, Wu CL, Chuang JY, Chen PY, Chu JM, Cheng SM, Qiu LY, Chang YC, Hwang DY, Huang CY, Lee JS, Chang KY.
Liu CC, et al. Among authors: chien ch.
Cell Death Dis. 2024 Jun 19;15(6):434. doi: 10.1038/s41419-024-06784-6.
Cell Death Dis. 2024.
PMID: 38898023
Free PMC article.